{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:01:57Z","timestamp":1768993317420,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006392","name":"Lausanne University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.clnu.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T10:51:01Z","timestamp":1680951061000},"page":"859-868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Nutritional and metabolic characteristics of critically ill patients admitted for severe toxidermia"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6717-7543","authenticated-orcid":false,"given":"Matthieu","family":"Karakus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6195-8947","authenticated-orcid":false,"given":"Olivier","family":"Pantet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Charri\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Favre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Gaide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5427-1648","authenticated-orcid":false,"given":"Mette M.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2023.04.006_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: A severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.clnu.2023.04.006_bib2","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-018-0793-7","article-title":"Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)","volume":"13","author":"Ingen-Housz-Oro","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clnu.2023.04.006_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40264-018-0711-x","article-title":"Stevens-johnson syndrome and toxic epidermal necrolysis in association with commonly prescribed drugs in outpatient care other than anti-epileptic drugs and antibiotics: a population-based case-control study","volume":"42","author":"Frey","year":"2019","journal-title":"Drug Saf"},{"key":"10.1016\/j.clnu.2023.04.006_bib4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1081-1206(10)60789-2","article-title":"Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"97","author":"Khalili","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clnu.2023.04.006_bib5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1272\/jnms.83.216","article-title":"A\u00a0review of the pathogenesis of toxic epidermal necrolysis","volume":"83","author":"Kinoshita","year":"2016","journal-title":"J\u00a0Nippon Med Sch"},{"key":"10.1016\/j.clnu.2023.04.006_bib6","series-title":"StatPearls. Treasure island (FL)","article-title":"Cutaneous adverse drug reaction","author":"Al Aboud","year":"2021"},{"key":"10.1016\/j.clnu.2023.04.006_bib7","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jaad.2020.02.066","article-title":"Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults","volume":"82","author":"Seminario-Vidal","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.clnu.2023.04.006_bib8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.clnu.2018.07.009","article-title":"Monitoring nutrition in the ICU","volume":"38","author":"Berger","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.04.006_bib9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/0884533616642746","article-title":"Nutrition in toxic epidermal necrolysis: a multicenter review","volume":"31","author":"Graves","year":"2016","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnu.2023.04.006_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.clnu.2018.01.025","article-title":"Trace element repletion following severe burn injury: a dose-finding cohort study","volume":"38","author":"Pantet","year":"2019","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnu.2023.04.006_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0305-4179(77)90004-3","article-title":"The evaporative water loss from burns and the water-vapour permeability of grafts and artificial membranes used in the treatment of burns","volume":"3","author":"Lamke","year":"1977","journal-title":"Burns"},{"key":"10.1016\/j.clnu.2023.04.006_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0305-4179(92)90035-S","article-title":"Cutaneous zinc and copper losses in burns","volume":"18","author":"Berger","year":"1992","journal-title":"Burns"},{"key":"10.1016\/j.clnu.2023.04.006_bib13","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/BCR.0b013e31817db8c8","article-title":"Blister fluid composition in a pediatric patient with toxic epidermal necrolysis","volume":"29","author":"Gandhi","year":"2008","journal-title":"J\u00a0Burn Care Res"},{"key":"10.1016\/j.clnu.2023.04.006_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clnu.2013.02.012","article-title":"ESPEN endorsed recommendations: nutritional therapy in major burns","volume":"32","author":"Rousseau","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.04.006_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0261-5614(02)00214-5","article-title":"Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.04.006_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clnu.2018.08.037","article-title":"ESPEN guideline on clinical nutrition in the intensive care unit","volume":"38","author":"Singer","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.04.006_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.burns.2015.10.025","article-title":"Moderate glycemic control safe in critically ill adult burn patients \u2013 a 15 year cohort study","volume":"42","author":"Stoecklin","year":"2016","journal-title":"Burns"},{"key":"10.1016\/j.clnu.2023.04.006_bib18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.clnu.2022.02.015","article-title":"ESPEN micronutrient guideline","volume":"41","author":"Berger","year":"2022","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.04.006_bib19","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.bjps.2016.01.034","article-title":"UK guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"69","author":"Creamer","year":"2016","journal-title":"J\u00a0Plast Reconstr Aesthetic Surg"},{"key":"10.1016\/j.clnu.2023.04.006_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/cc13991","article-title":"Albumin administration in the acutely ill: what is new and where next?","volume":"18","author":"Vincent","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.clnu.2023.04.006_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3945\/ajcn.111.023812","article-title":"Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements","volume":"95","author":"Duncan","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnu.2023.04.006_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinorgbio.2016.02.012","article-title":"The neglected role of copper ions in wound healing","volume":"161","author":"Kornblatt","year":"2016","journal-title":"J\u00a0Inorg Biochem"},{"key":"10.1016\/j.clnu.2023.04.006_bib23","doi-asserted-by":"crossref","first-page":"tkab047","DOI":"10.1093\/burnst\/tkab047","article-title":"Role of copper nanoparticles in wound healing for chronic wounds: literature review","volume":"10","author":"Salvo","year":"2022","journal-title":"Burns Trauma"},{"key":"10.1016\/j.clnu.2023.04.006_bib24","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(97)11369-1","article-title":"Toxic epidermal necrolysis","volume":"351","author":"Becker","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2023.04.006_bib25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0190-9622(90)70333-D","article-title":"Toxic epidermal necrolysis (Lyell syndrome)","volume":"23","author":"Roujeau","year":"1990","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.clnu.2023.04.006_bib26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.clnu.2016.05.007","article-title":"Impact of decreasing energy intakes in major burn patients: a 15 year retropective cohort study","volume":"36","author":"Pantet","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnu.2023.04.006_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423001127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423001127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:12:05Z","timestamp":1759367525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561423001127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0261561423001127"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2023.04.006","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutritional and metabolic characteristics of critically ill patients admitted for severe toxidermia","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}